The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study
scientific article
Author/s
author:
Ricardo Machado Xavier,
Karel Pavelka,
Mahboob Rahman,
Bonnie Vlahos,
Ehab Mahgoub
Wikidata